ytterbium and organophosphonates
ytterbium has been researched along with organophosphonates in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Kovacs, Z; Li, X; Sherry, AD; Zhang, S; Zhao, P | 1 |
Banerjee, S; Chakraborty, S; Das, T; Mathew, B; Pillai, MR; Samuel, G; Sarma, HD; Venkatesh, M | 1 |
Afarideh, H; Vaez-Tehrani, M; Yousefnia, H; Zolghadri, S | 1 |
Other Studies
3 other study(ies) available for ytterbium and organophosphonates
Article | Year |
---|---|
Synthesis and NMR studies of new DOTP-like lanthanide(III) complexes containing a hydrophobic substituent on one phosphonate side arm.
Topics: Animals; Chemical Phenomena; Chemistry, Physical; Heart; Hydrolysis; In Vitro Techniques; Lanthanoid Series Elements; Ligands; Magnetic Resonance Spectroscopy; Male; Molecular Conformation; Molecular Structure; Nitrobenzenes; Organophosphonates; Organophosphorus Compounds; Rats; Rats, Sprague-Dawley; Sodium; Stereoisomerism; Thulium; Ytterbium | 2001 |
175Yb labeled polyaminophosphonates as potential agents for bone pain palliation.
Topics: Animals; Bone and Bones; Bone Neoplasms; Hydrogen-Ion Concentration; Organophosphonates; Pain; Palliative Care; Radiopharmaceuticals; Rats; Rats, Wistar; Spectrometry, Gamma; Tissue Distribution; Ytterbium | 2004 |
Human absorbed dose estimation for a new (175)Yb-phosphonate based on rats data: Comparison with similar bone pain palliation agents.
Topics: Animals; Bone Neoplasms; Humans; Organophosphonates; Pain; Pain Management; Radiation Dosage; Rats; Tissue Distribution; Ytterbium | 2016 |